Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 415

Similar articles for PubMed (Select 14630828)

1.

Hyperprothrombinemia associated with prothrombin G20210A mutation inhibits plasma fibrinolysis through a TAFI-mediated mechanism.

Colucci M, Binetti BM, Tripodi A, Chantarangkul V, Semeraro N.

Blood. 2004 Mar 15;103(6):2157-61. Epub 2003 Nov 20.

2.

Hyperprothrombinaemia-induced APC resistance: differential influence on fibrin formation and fibrinolysis.

Binetti BM, Rotunno C, Tripodi A, Asti D, Semeraro F, Semeraro N, Colucci M.

Thromb Haemost. 2006 Apr;95(4):606-11.

PMID:
16601829
3.

Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis.

Colucci M, Binetti BM, Branca MG, Clerici C, Morelli A, Semeraro N, Gresele P.

Hepatology. 2003 Jul;38(1):230-7.

PMID:
12830006
4.

Tissue factor-expressing monocytes inhibit fibrinolysis through a TAFI-mediated mechanism, and make clots resistant to heparins.

Semeraro F, Ammollo CT, Semeraro N, Colucci M.

Haematologica. 2009 Jun;94(6):819-26. doi: 10.3324/haematol.2008.000042. Epub 2009 Apr 18.

5.

Effect of heparin on TAFI-dependent inhibition of fibrinolysis: relative importance of TAFIa generated by clot-bound and fluid phase thrombin.

Colucci M, Pentimone A, Binetti BM, Cramarossa M, Piro D, Semeraro N.

Thromb Haemost. 2002 Aug;88(2):282-7.

PMID:
12195701
6.

Effect of warfarin treatment on thrombin activatable fibrinolysis inhibitor (TAFI) activation and TAFI-mediated inhibition of fibrinolysis.

Incampo F, Carrieri C, Galasso R, Scaraggi FA, Di Serio F, Woodhams B, Semeraro N, Colucci M.

J Thromb Haemost. 2013 Feb;11(2):315-24. doi: 10.1111/jth.12102.

PMID:
23256818
7.

Thrombin activatable fibrinolysis inhibitor (TAFI) does not inhibit in vitro thrombolysis by pharmacological concentrations of t-PA.

Colucci M, D'Aprile AM, Italia A, Gresele P, Morser J, Semeraro N.

Thromb Haemost. 2001 Apr;85(4):661-6.

PMID:
11341502
10.

Antithrombotic effects due to pharmacological modulation of thrombin-activatable fibrinolysis inhibitor in rats.

Soni H, Sharma A, Bhatt S, Jain MR, Patel PR.

Pharmacology. 2008;82(4):304-9. doi: 10.1159/000165118. Epub 2008 Oct 21.

PMID:
18936552
11.

Thrombin activatable fibrinolysis inhibitor (TAFI): a molecular link between coagulation and fibrinolysis.

Miljić P, Heylen E, Willemse J, Djordjević V, Radojković D, Colović M, Elezović I, Hendriks D.

Srp Arh Celok Lek. 2010 Jan;138 Suppl 1:74-8. Review.

PMID:
20229688
12.
13.

Thrombin activatable fibrinolysis inhibitor (TAFI)--how does thrombin regulate fibrinolysis?

Bouma BN, Mosnier LO.

Ann Med. 2006;38(6):378-88. Review.

PMID:
17008302
14.

Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1.

Meltzer ME, Lisman T, de Groot PG, Meijers JC, le Cessie S, Doggen CJ, Rosendaal FR.

Blood. 2010 Jul 8;116(1):113-21. doi: 10.1182/blood-2010-02-267740. Epub 2010 Apr 12.

15.

A new functional assay of thrombin activatable fibrinolysis inhibitor.

Guimarães AH, Bertina RM, Rijken DC.

J Thromb Haemost. 2005 Jun;3(6):1284-92.

PMID:
15946219
17.

Thrombin-activable fibrinolysis inhibitor zymogen does not play a significant role in the attenuation of fibrinolysis.

Foley JH, Kim P, Nesheim ME.

J Biol Chem. 2008 Apr 4;283(14):8863-7. doi: 10.1074/jbc.M800127200. Epub 2008 Feb 5.

18.

An antifibrinolytic mechanism describing the prothrombotic effect associated with factor VLeiden.

Bajzar L, Kalafatis M, Simioni P, Tracy PB.

J Biol Chem. 1996 Sep 20;271(38):22949-52.

19.

Factor IX-Padua enhances the fibrinolytic resistance of plasma clots.

Ammollo CT, Semeraro F, Colucci M, Simioni P.

Thromb Haemost. 2014 Feb;111(2):226-32. doi: 10.1160/TH13-06-0489. Epub 2013 Oct 17.

PMID:
24136406
20.

Deficiency in thrombin-activatable fibrinolysis inhibitor (TAFI) protected mice from ferric chloride-induced vena cava thrombosis.

Wang X, Smith PL, Hsu MY, Tamasi JA, Bird E, Schumacher WA.

J Thromb Thrombolysis. 2007 Feb;23(1):41-9.

PMID:
17111204
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk